Continuous Disclosure Policy

As an ASX listed company, CBio Limited is required to comply with the continuous disclosure regime in section 674 of the Corporations Act and Listing Rule 3.1 which entrenches the statutory requirements of section 674 to which statutory liability for its breach attaches.

This document sets out the Board’s continuous disclosure policies as adopted by the Board on the Adoption Date.

Posted in ASX Releases